Did You Know?

Editor’s Picks

Latest News

NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2022 – Has Sufficient Cash, NV-CoV-2 Coronavirus Drug Candidate Progressing Further for Clinical Trials Application

Sorrento Announces FDA Authorization to Proceed With Phase 2 Study of Abivertinib (Fujovee™) to Treat Metastatic Castrate Resistant Prostate Cancer (MAVERICK Trial)

FDA granted IND clearance for Abivertinib (Fujovee™) for the Phase 2 MAVERICK study to be conducted in participants with metastatic...

Cardiol Therapeutics Announces FDA Investigational New Drug Application (IND) Authorization for Multicenter Phase II Open-Label Pilot Study of CardiolRx(TM) for Recurrent Pericarditis

Third IND authorization for CardiolRx™ in cardiovascular diseaseStudy to run in parallel with Company's multi-national Phase II acute myocarditis trial,...

Model N Spring 2022 Product Release Brings New Channel Efficiencies for High-Tech and Enhanced Automation and Compliance for Life Sciences

Revenue Optimization Leader Introduces Payments Functionality, Enhances Pricing Capabilities, and Delivers More International Operations Support SAN MATEO, Calif.--(BUSINESS WIRE)--#ModelN--Model N,...

error: Content is protected !!